Mahrokhian, Shant H. http://orcid.org/0000-0003-4094-8739
Tostanoski, Lisa H. http://orcid.org/0000-0001-9255-5684
Jacob-Dolan, Catherine http://orcid.org/0000-0001-6641-0342
Zahn, Roland C. http://orcid.org/0000-0003-2822-6231
Wegmann, Frank http://orcid.org/0000-0002-9821-1492
McMahan, Katherine
Yu, Jingyou
Gebre, Makda S. http://orcid.org/0000-0001-8520-2178
Bondzie, Esther A.
Wan, Huahua
Powers, Olivia
Ye, Tianyi
Barrett, Julia
Schuitemaker, Hanneke http://orcid.org/0000-0001-8563-2266
Barouch, Dan H. http://orcid.org/0000-0001-5127-4659
Funding for this research was provided by:
Janssen Research and Development
Ragon Institute of MGH, MIT and Harvard
Janssen Vaccines & Prevention, MassCPR, Ragon Institute
Article History
Received: 3 November 2021
Accepted: 31 January 2022
First Online: 23 February 2022
Competing interests
: D.H.B., R.C.Z., F.W., and H.S. are co-inventors on provisional vaccine patents (63/121,482; 63/133,969; 63/135,182). R.C.Z., F.W., and H.S. are employees of Janssen Vaccines & Prevention B.V., a Janssen Pharmaceutical Company of Johnson & Johnson, at the time of the study, and may have ownership of shares in Johnson & Johnson.